Leukemia & lymphoma/Leukemia and lymphoma · 2019 · 27 citations · 30 references
MedicineHematologyIron Metabolism DisordersStem Cell TransplantationTransfusion MedicineHematologic ToxicityHematopoietic ToxicityIron Chelation TherapyIron DeficiencyMyelodysplastic SyndromesTransfusion SupportFerritin ElevationFerritin StatusMarrow Iron DepletionMyelodysplastic Syndromes TransplantationNon-relapse MortalityOverall MortalityRelapse IncidenceRelapse-free Survival
= .04). This study illustrates the impact of RBCT and related parameters on HSCT-outcome. Patients with an expected prolonged survival after transplantation may benefit from early iron reduction therapy after transplantation.
30
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg, Heinz Tuechler, Julie Schanz et al. · Blood · 2012 · 3.1K citations · Full text
Julie Schanz, Heinz Tüchler, Françesc Solé et al. · Journal of Clinical Oncology · 2012 · 691 citations · Full text
Medicine, Hematology, Oncology +17